Effective and alternative treatment of anastomotic leak after gastrojejunal bypass: endoluminal vacuum therapy

Rev Esp Enferm Dig. 2024 Jan;116(1):52-53. doi: 10.17235/reed.2023.9675/2023.

Abstract

Anastomotic leak (AL) after with Roux-en-Y gastric bypass (RYGB) has a morbidity rate to 53% and it can be potentially lethal (mortality rate from 0.5 to 10%). In these cases, surgery is usually a challenge, so in recent years minimally invasive endoscopic treatment is gaining ground. Endoluminal vacuum therapy (EVAC) is a promising treatment that is being used in esophagogastric and rectal surgery for the management of AL. We present the case of a patient on his 5th postoperative day of bariatric surgery (RYGB) with an acute abdomen. He was diagnosed of dehiscence of gastrojejunal anastomosis and he needed urgent surgery twice. Subsequently, in control CT, a new anastomotic leak is evidenced. However, given the clinical stability of the patient, it was decided to start EVAC type ESO-Sponge® placed by endoscopy. A total of 4 changes are made every 3-4 days with a total duration of treatment of 15 days. EVAC was removed when the defect presented a 1 mm sized.

Publication types

  • Case Reports

MeSH terms

  • Anastomotic Leak / surgery
  • Bariatric Surgery*
  • Endoscopy, Gastrointestinal
  • Gastric Bypass* / adverse effects
  • Humans
  • Male
  • Negative-Pressure Wound Therapy*
  • Obesity, Morbid* / surgery
  • Retrospective Studies